title: [Type 2 diabetes mellitus with histological finding of nonalcoholic steatohepatitis following combination therapy with interferon and ribavirin for chronic hepatitis C].
authors.affiliation: Department of Internal Medicine, Kohan Hospital.
authors.forename: Norio
authors.initials: N
authors.lastname: Yagi
authors.forename: Osamu
authors.initials: O
authors.lastname: Uchikoga
authors.forename: Tomoko
authors.initials: T
authors.lastname: Nishumi
authors.forename: Yuki
authors.initials: Y
authors.lastname: Shibutani
authors.forename: Kaoru
authors.initials: K
authors.lastname: Fukunaga
authors.forename: Norio
authors.initials: N
authors.lastname: Yagi
authors.forename: Munetaka
authors.initials: M
authors.lastname: Morita
authors.forename: Satoshi
authors.initials: S
authors.lastname: Tani
authors.forename: Shinichi
authors.initials: S
authors.lastname: Murao
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005234:Fatty Liver / Q000139:chemically induced*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons